NDC 15631-0390

SANTONINUM

Santoninum

SANTONINUM is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Santonin.

Product ID15631-0390_a1be4558-b5b1-0a0d-e053-2a95a90a0dfa
NDC15631-0390
Product TypeHuman Otc Drug
Proprietary NameSANTONINUM
Generic NameSantoninum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-10-31
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameSANTONIN
Active Ingredient Strength6 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 15631-0390-0

100 PELLET in 1 VIAL, SINGLE-DOSE (15631-0390-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0390-3 [15631039003]

SANTONINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-26

NDC 15631-0390-1 [15631039001]

SANTONINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-26

NDC 15631-0390-4 [15631039004]

SANTONINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-26

NDC 15631-0390-5 [15631039005]

SANTONINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-26

NDC 15631-0390-2 [15631039002]

SANTONINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-26

NDC 15631-0390-0 [15631039000]

SANTONINUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-26

Drug Details

Active Ingredients

IngredientStrength
SANTONIN6 [hp_X]/1

OpenFDA Data

SPL SET ID:a673abf8-7230-406a-be05-461d182ac1d1
Manufacturer
UNII

NDC Crossover Matching brand name "SANTONINUM" or generic name "Santoninum"

NDCBrand NameGeneric Name
0220-4558SantoninumSANTONIN
15631-0390SANTONINUMSANTONINUM
68428-622SantoninumSANTONIN
71919-609SantoninumSANTONIN

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.